[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE552001T1 - Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern - Google Patents

Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern

Info

Publication number
ATE552001T1
ATE552001T1 AT08859308T AT08859308T ATE552001T1 AT E552001 T1 ATE552001 T1 AT E552001T1 AT 08859308 T AT08859308 T AT 08859308T AT 08859308 T AT08859308 T AT 08859308T AT E552001 T1 ATE552001 T1 AT E552001T1
Authority
AT
Austria
Prior art keywords
nervous
restoration
demyelinating diseases
nervous system
sheath
Prior art date
Application number
AT08859308T
Other languages
English (en)
Inventor
Evgeny Veniaminovich Arzamastsev
Klavdia Ignatievna Malinovskaya
Margarita Ivanovna Mironova
Original Assignee
Sbiogen Technologiess Aozt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbiogen Technologiess Aozt filed Critical Sbiogen Technologiess Aozt
Application granted granted Critical
Publication of ATE552001T1 publication Critical patent/ATE552001T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT08859308T 2007-12-06 2008-12-05 Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern ATE552001T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2007145037/15A RU2355413C1 (ru) 2007-12-06 2007-12-06 Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы, средство, способствующее восстановлению миелиновой оболочки нервного волокна, и способ лечения демиелинизирующих заболеваний нервной системы
PCT/RU2008/000747 WO2009075607A2 (en) 2007-12-06 2008-12-05 Pharmaceutical preparation for treating demyelinating diseases of the nervous system; preparation promoting restoration of the myelin sheath of nerve fibers; and a method for treating demyelinating diseases of the nervous system

Publications (1)

Publication Number Publication Date
ATE552001T1 true ATE552001T1 (de) 2012-04-15

Family

ID=40756011

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08859308T ATE552001T1 (de) 2007-12-06 2008-12-05 Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern

Country Status (18)

Country Link
US (2) US8440683B2 (de)
EP (1) EP2271340B1 (de)
JP (1) JP5485166B2 (de)
KR (1) KR20100113505A (de)
CN (1) CN101888842B (de)
AT (1) ATE552001T1 (de)
CA (1) CA2707681C (de)
CY (1) CY1112818T1 (de)
DK (1) DK2271340T3 (de)
EA (1) EA201000786A1 (de)
ES (1) ES2383315T3 (de)
HR (1) HRP20120422T1 (de)
PL (1) PL2271340T3 (de)
PT (1) PT2271340E (de)
RU (1) RU2355413C1 (de)
SI (1) SI2271340T1 (de)
UA (1) UA97875C2 (de)
WO (1) WO2009075607A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102526648B1 (ko) * 2015-08-21 2023-04-27 삼성전자주식회사 2,5-디히드록시벤젠술폰산을 포함하는 신경세포의 수초화를 촉진하기 위한 조성물 및 그의 용도
WO2019138356A1 (en) 2018-01-11 2019-07-18 M et P Pharma AG Treatment of demyelinating diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU1713151C (ru) * 1986-07-05 1995-02-09 Научно-производственное объединение "ВНИИ лекарственных и ароматических растений" Средство для лечения травматических и послеоперационных повреждений периферической нервной системы
RU2089610C1 (ru) * 1994-03-29 1997-09-10 Институт физиологии растений им.К.А.Тимирязева РАН Штамм культивируемых клеток растенийй stephania glabra (roxb) miers - продуцент стефарина
WO2003049761A1 (en) 2000-12-08 2003-06-19 Neuronz Limited Use of insuline-like growth factor-i for promoting remyelination of axons
WO2003041655A2 (en) 2001-11-13 2003-05-22 Loi Tran Therapeutic agent composition and method of use

Also Published As

Publication number Publication date
CN101888842B (zh) 2012-07-04
PT2271340E (pt) 2012-06-01
CN101888842A (zh) 2010-11-17
DK2271340T3 (da) 2012-06-11
CA2707681C (en) 2013-01-08
WO2009075607A2 (en) 2009-06-18
UA97875C2 (ru) 2012-03-26
CA2707681A1 (en) 2009-06-18
US20100267756A1 (en) 2010-10-21
US8440683B2 (en) 2013-05-14
PL2271340T3 (pl) 2012-09-28
KR20100113505A (ko) 2010-10-21
CY1112818T1 (el) 2016-02-10
EP2271340B1 (de) 2012-04-04
RU2355413C1 (ru) 2009-05-20
EP2271340A2 (de) 2011-01-12
SI2271340T1 (sl) 2012-07-31
US20130226133A1 (en) 2013-08-29
JP5485166B2 (ja) 2014-05-07
HRP20120422T1 (hr) 2012-06-30
ES2383315T3 (es) 2012-06-20
WO2009075607A3 (en) 2009-10-29
EA201000786A1 (ru) 2010-12-30
JP2011506316A (ja) 2011-03-03

Similar Documents

Publication Publication Date Title
EA201791669A2 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
EA201000603A1 (ru) ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ
MX2011007854A (es) Metodos para tratar infartos agudos al miocardio y trastornos relacionados.
EA201200686A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
WO2009038720A3 (en) Method and apparatus for applying light therapy
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
EA201590655A1 (ru) Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений
EA201071243A1 (ru) Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом
EA201590353A1 (ru) Способы лечения болезни альцгеймера и фармацевтические композиции
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA201070740A1 (ru) Способ лечения перелома кости антителами против склеростина
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
EA201590654A1 (ru) Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона
MX2010012860A (es) Metodos para tratar cancer del sistema nervioso central.
EA200802020A1 (ru) Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1
EA201492279A1 (ru) Лекарственное средство для предупреждения и/или лечения поликистозной болезни почек
EA201300988A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
BR112012009121A2 (pt) Novas composições para a prevenção e/ou tratamento de distúrbios degenerativos do sistema nervoso central
BR112012010518A2 (pt) composto, composição farmacêutica, uso de composto, métodos para estimular um receptor de cb, para tratar uma doença, um distúrbio ou uma condição, para diminuir dano secundário, para a formação de c-amp, processo para a preparação de um composto, e, método para estímulo do crescimento ósseo, massa óssea, reparo ósseo ou prevenção da perda óssea.
ATE555131T1 (de) Verfahren zur behandlung von erkrankungen mit knochenabbau unter verwendung eines gm-csf- antagonisten
ATE445644T1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
BRPI0917245A8 (pt) Compostos derivados de isoquinolinona e sua composição farmacêutica
ATE552001T1 (de) Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern